New Method to Measure Sulfatinib and Its Interaction with Myricetin in Rats
Author Information
Author(s): Chen Dongxin, Chen Jie, Xia Hailun, Chen Xiaohai, Hu Jinyu, Wu Guangliang, Xu Xuegu
Primary Institution: The First Affiliated Hospital of Wenzhou Medical University
Hypothesis
The study aims to develop a UPLC-MS/MS method for detecting sulfatinib and to investigate its interaction with myricetin in rats.
Conclusion
The study found no significant interaction between sulfatinib and myricetin in rats.
Supporting Evidence
- The method demonstrated high linearity over a concentration range of 11–2,000 ng/mL.
- The lower limit of quantification for sulfatinib was established at 1 ng/mL.
- Pharmacokinetic parameters showed no significant differences when sulfatinib was administered with myricetin.
Takeaway
Researchers created a new way to measure a cancer drug called sulfatinib in rats and checked if it interacts with another substance called myricetin, but they found no interaction.
Methodology
The study used UPLC-MS/MS to quantitatively detect sulfatinib in rat plasma and assessed its interaction with myricetin.
Limitations
The study's findings may be limited by the small sample size and the doses of myricetin used.
Participant Demographics
Male Sprague-Dawley rats, weighing 200 ± 10 g.
Statistical Information
Statistical Significance
p>0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website